Monashee Investment Management »

Mersana Therapeutics shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.4M 310k 4.48
2020-06-30 $7.0M 300k 23.40
2017-06-30 $1.5M 108k 13.97

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Anheuser Busch Inbev Sa Sponsored Adr (BUD)
Sharkninja Com Shs (SN)
Aercap Holdings Nv SHS (AER)
Kaspi Kz Jsc Sponsored Ads (KSPI)
American Healthcare Reit Com Shs (AHR)
Oddity Tech Shs Cl A (ODD)
General Electric Com New (GE)

View all positions for Monashee Investment Management

Top funds holding Mersana Therapeutics

EcoR1 Capital
VR Adviser
Bain Capital Life Sciences Investors
BlackRock
Vanguard Group
Nextech Invest
Balyasny Asset Management
Citadel Advisors
Rock Springs Capital Management
Morgan Stanley
Woodline Partners
Cormorant Asset Management
Geode Capital Management
Deutsche Bank Aktiengesellschaft
Millennium Management

View all funds holding Mersana Therapeutics